Mary T Szela's Net Worth
$17.5 Million
Who is Mary T Szela?
Mary T Szela has an estimated net worth of $17.5 Million. This is based on reported shares across multiple companies, which include ABBOTT LABORATORIES, Prometheus Biosciences, Inc., Receptos, Inc., Omega Therapeutics, Inc., Kura Oncology, Inc., Coherus BioSciences, Inc., NOVELION THERAPEUTICS INC., ALIMERA SCIENCES INC, Aegerion Pharmaceuticals, Inc., and TriSalus Life Sciences, Inc..
SEC CIK
Mary T Szela's CIK is 0001410289
Past Insider Trading and Trends
2008 was Mary T Szela's most active year for acquiring shares with 21 total transactions. Mary T Szela's most active month to acquire stocks was the month of January. 2011 was Mary T Szela's most active year for disposing of shares, totalling 38 transactions. Mary T Szela's most active month to dispose stocks was the month of November. 2011 saw Mary T Szela paying a total of $3,620,938.73 for 122,561 shares, this is the most they've acquired in one year. In 2015 Mary T Szela cashed out on 26,200 shares for a total of $3,619,376.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ABBOTT LABORATORIES (ABT) Snapshot price: $113.17
Senior Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$54.01 | -$40,820.82 | 119.34K |
Dec 14
| |||
Form 4
|
—
|
0
|
$48.69 | -$18,019.15 | 119.34K |
Mar 31
| |||
Form 4
| -19.60% | -29.10K |
$47.97 | -$1,395,904.62 | 119.34K |
Feb 28 - Mar 1
| |||
Form 4
| +17.59% | 22.2K |
—
|
—
| 148.44K |
Feb 18
| |||
Form 4
| -0.16% | -200.00 |
—
|
—
| 126.24K |
Nov 23
| |||
Form 4
| -1.42% | -1.81K |
$49.50 | -$89,842.50 | 126.44K |
Aug 27
| |||
Form 4
| -20.09% | -32.24K |
$54.35 | -$1,752,113.46 | 128.26K |
Feb 26 - Mar 1
| |||
Form 4
| +33.86% | 40.6K |
—
|
—
| 160.5K |
Feb 19
| |||
Form 4
| -4.74% | -5.96K |
$53.93 | -$321,532.76 | 119.89K |
Feb 16
| |||
Form 4
|
—
|
0
|
$52.96 | -$226.84 | 125.86K |
Feb 10
| |||
Form 4
| -0.81% | -1.03K |
$46.07 | -$47,267.82 | 125.86K |
Aug 27
| |||
Form 4
| -100.00% | -8.12K |
$41.57 | -$337,593.37 |
0
|
May 1
| |||
Form 4
| -3.11% | -4.07K |
$50.58 | -$205,961.76 | 126.88K |
Feb 27
| |||
Form 4
| +37.19% | 35.5K |
—
|
—
| 130.96K |
Feb 20
| |||
Form 4
| -1.69% | -1.65K |
$54.80 | -$90,151.95 | 95.45K |
Feb 17
| |||
Form 4
| +0.46% | 449 |
$51.22 | -$14,140.96 | 97.1K |
Feb 4 - Feb 4
| |||
Form 4
|
—
|
0
|
$55.20 | -$3,344.00 | 96.65K |
Feb 3
| |||
Form 4
| +0.46% | 438 |
$51.23 | -$3,632.03 | 96.65K |
Sep 8
| |||
Form 4
| +0.93% | 884 |
$47.68 | -$58,990.36 | 96.21K |
Aug 26 - Aug 27
| |||
Form 4
| +1.66% | 1.56K |
$51.41 | -$58,211.68 | 95.33K |
Jul 9
| |||
Form 4
| -2.67% | -2.57K |
$52.91 | -$135,914.10 | 93.77K |
Jun 30
| |||
Form 4
| +0.77% | 733 |
$48.53 | -$5,176.29 | 96.34K |
May 14
| |||
Form 4
| +2.82% | 2.63K |
$47.03 | -$90,624.13 | 95.61K |
May 6
| |||
Form 4
| -1.44% | -1.36K |
$54.16 | -$73,823.70 | 92.98K |
Feb 29
| |||
Form 4
| +30.00% | 21.77K |
$55.62 | $1,209,313.14 | 94.34K |
Feb 15 - Feb 19
| |||
Form 4
| -10.29% | -8.33K |
$52.50 | -$437,167.50 | 72.57K |
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +13.78% | 9.8K |
$52.14 | $510,972.00 | 80.9K |
Aug 27
| |||
| No matching records found | |||||||||
Prometheus Biosciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.07K |
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
∞
| 2.07K |
—
|
—
| 2.07K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Receptos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.40K |
—
|
—
|
0
|
Aug 27
| |||
Form 4
|
∞
| 7.4K |
—
|
—
| 7.4K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Omega Therapeutics, Inc. (OMGA) Snapshot price: $3.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kura Oncology, Inc. (KURA) Snapshot price: $20.615
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||